Accepted Insurance List |Dermatology Alliance

Tax ID 264429299

NPI 1558569087

IN NETWORK

AARP Medicare Complete Secure Horizons (HMO)

  • North Texas Specialty Physicians – REFERRAL REQUIRED
  • PIPA- no referral
  • WELLMED-Optum-no referral
  • NTX- no referral

Aetna PPO

Aetna- Silver plan (part of exchange program)

Aetna HMO – REFERRAL REQUIRED

Aetna TRS

  • TRS Activecare 1- no referral
  • TRS Activecare 2- no referral
  • TRS Activecare select- DO NOT ACCEPT

Aetna Medicare Advantage/PRIME HMO/PPO-REFERRAL REQUIRED

APWU- Part of Cigna Network

BCBS TX EPO/PPO no referral

BCBS TX PPO/POS+ no referral

Blue Advantage PPO (Exchange Product)-REFERRAL REQUIRED

Blue Premier HMO- REFERRAL RQUIRED

Blue Premier Access- No referral

Blue Cross and Blue shield Medicare Advantage

Blue Essentials (HMO plan)– REFERRAL REQUIRED

Blue Essentials Access- Open Access no referral required

Cigna PPO

Coventry PPO

First Health PPO

Freedom life- part of Cigna Network (request pt to call if a particular dx is covered under their plan)

Galaxy Health Network PPO

GEHA- United Shared Services

Golden Rule

Healthsmart Accell PPO

Healthsmart GEPO

Healthsmart PPO

Humana choice Care

Humana PPO

Humana One

Humana TRS Medicare Advantage

IMS PPO

Liberty Mutual

Medicare – Traditional

Medicare Railroad

Medi-share

Meritain Health

Multi-Plan

Mutual of Omaha

PHCS

 

United Healthcare One

United Healthcare Medicare Advantage

United Healthcare PPO

United Healthcare (MyAllsavers) & (Student Resources) PPO

United Healthcare Medicare complete

United Healthcare Health select- REFERRAL REQUIRED

United Healthcare Improvement Plus

UMR PPO

UMR—compass balance- this one is different from UHC compass, which we are out of network

Wellmed

Wellmed-Optum

Out of Network

Care “N” Care – plan has out-of network benefits

Aetna TRS Activecare Select– Teachers plan

Aetna (Baylor Scott and white and Whole Health Network) Control #866344

BCBS Medicare Advantage HMO (not offered in Tarrant County, not participating)

Cigna LOCAL plus

Cigna Focus HMO

Cigna Care Designation

First Care

Cigna Healthspring (ppo)

Rocky Mountain Health Plan PPO

United Healthcare COMPASS, CHARTER, CORE

Humana Medicare HMO/PPO

OSCAR

Smart Care- is a Baylor Scott and White Network

Scott and White HMO

Do not accept any Medicaid plans, ex. CHIP, Molina, TMHP,

Out of Network with NTSP, Referral required to be seen

Tricare South

Tricare Reserve select

Tricare Prime/HMO (can be seen only with a Referral/Auth from PCP)

BOOK AN APPOINTMENT

VISIT OUR OTHER LOCATIONS

KELLER LOCATION

12469 Timberland Blvd #501
Fort Worth, TX 76244

Fax: 817.431.7979

817-431-6555

COPPELL LOCATION

215 South Denton Tap Rd Suite 170 Coppell, TX 75019

Fax: 972.304.6050

469-312-7302

ROANOKE LOCATION

206 Denton Dr
Roanoke, TX 76262

Fax: 682.237.2274

682-237-2271

SPECIAL OFFERS

We accept several insurance providers. Check out the complete list to see if you are covered.

Safety Information

Critical Details About Compounded Semaglutide

Compounded medications are legally allowed to be prescribed under federal law; however, they are not FDA-approved and do not undergo FDA evaluation for safety, efficacy, or production standards. At DermatologyAlliance, compounded semaglutide is prescribed based on an individualized medical assessment.

WARNING: Potential Risk of Thyroid C-Cell Tumors
Research in animals has linked semaglutide, the active ingredient in some GLP-1 receptor agonists, to thyroid tumors, including medullary thyroid carcinoma (MTC). It is unclear if semaglutide causes similar tumors in humans. Notify your healthcare provider immediately if you notice symptoms of thyroid cancer, such as neck lumps or swelling, hoarseness, swallowing difficulties, or shortness of breath. Compounded semaglutide is not suitable for individuals with personal or family histories of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Uses of Compounded Semaglutide
Compounded semaglutide is intended for use alongside a reduced-calorie diet and increased physical activity to manage chronic weight in adults who meet the following criteria:

  • A body mass index (BMI) of 30 kg/m² or higher (classified as obesity), or
  • A BMI of 27 kg/m² or higher (overweight) with at least one weight-related condition, such as type 2 diabetes, hypertension, or abnormal cholesterol levels.

Usage Restrictions

  • Do not use compounded semaglutide in combination with other GLP-1 receptor agonists or semaglutide-containing products.
  • Its safety and effectiveness when combined with other weight management medications have not been established.
  • Patients with a history of pancreatitis or gastroparesis have not been studied for this treatment.

Avoid Use If You:

  • Have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
  • Are diagnosed with type 1 diabetes, pancreatitis, or gastroparesis.
  • Are allergic to semaglutide or any inactive ingredients.
  • Have a history of suicidal thoughts or behavior.

Precautions and Warnings:

  • Acute Pancreatitis: Stop using the medication if pancreatitis is suspected.
  • Gallbladder Issues: Monitor for symptoms of gallbladder disease, including gallstones, and seek medical advice as needed.
  • Low Blood Sugar: When combined with insulin or similar medications, there is an increased risk of hypoglycemia. Regularly monitor blood sugar and adjust doses as recommended by your provider.
  • Kidney Health: Monitor kidney function, particularly in patients with renal impairment or those experiencing severe gastrointestinal effects.
  • Mental Health Concerns: Watch for mood changes, depression, or suicidal thoughts, and discontinue use if these symptoms occur.

Pregnancy and Fertility Considerations
Semaglutide may harm an unborn child. Avoid use during pregnancy or if planning to become pregnant. Stop treatment at least two months before attempting to conceive.

Common Side Effects:
Frequently reported side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, headaches, and low blood sugar in patients with type 2 diabetes.

Potential Drug Interactions:
Compounded semaglutide slows gastric emptying, which could impact the absorption of oral medications. Consult your healthcare provider to manage potential interactions effectively.

Medication Disclaimer

Essential Information on Medications: Saxenda®, Victoza®, Wegovy®, and Ozempic® are patented products of Novo Nordisk™, while Eli Lilly and Company™ produce Mounjaro™ and Zepbound. This website is not affiliated with, endorsed by, or connected to these companies or their products in any capacity. While these FDA-approved medications may be available through other sources, we do not provide them, and they are currently experiencing supply shortages. During such shortages, pharmacies might prepare compounded versions of these drugs, provided they comply with the Federal Food, Drug, and Cosmetic Act’s requirements. Compounded medications are valuable for patients with unique medical needs that FDA-approved drugs cannot address. However, it is important to note that compounded drugs are not FDA-approved, nor do they undergo premarketing evaluations for safety, effectiveness, or quality. The FDA has not assessed these medications for their intended uses, nor has the manufacturing process for compounded drugs been reviewed by the FDA.